Back

MindWalk pursues larger ReefIQ drugmaker contracts as Q1 loss widens

Verifying
  • MindWalk is negotiating ReefIQ enterprise deployments with multiple large pharmaceutical companies.
  • Revenue reached C$3.8 million, up 21% year over year.
  • Sanabil committed a US$30 million senior unsecured revolving credit facility.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.